Opko Health (OPK) EBITDA Margin (2009 - 2026)
Opko Health's EBITDA Margin was -13.07% in Q3 2026, up 5.85 percentage points from -18.92% a year earlier but down 22.59 percentage points from the prior quarter.
Opko Health (OPK) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Opko Health's EBITDA Margin was 0.47% through Sep 30, 2026, up 17.81 percentage points year-over-year; for FY2025, it was -3.39%, up 3.89 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -13.41 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -7.28% in FY2024 (-1.43 pp), -5.85% in FY2023 (+5.75 pp), -11.60% in FY2022 (-17.13 pp) and 5.54% in FY2021 (-4.49 pp).
- Quarterly EBITDA Margin has moved between -33.12% (Q3 2022) and 16.18% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin has increased for five straight quarters, with an average year-over-year change of +10.49 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2026 (a gain of 30.20 percentage points); the worst was Q3 2022 (a drop of 47.89 percentage points).
- Per Business Quant data, OPK's EBITDA Margin in the three quarters before Q3 2026 was 9.52% (Q2 2026), -23.09% (Q1 2026) and 16.18% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Opko Health | 1.27 Bn | -393.40 Mn | 42.06 Mn | -13.07% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13.07% |
| Jun 30, 2026 | 9.52% |
| Mar 31, 2026 | -23.09% |
| Dec 31, 2025 | 16.18% |
| Sep 30, 2025 | -18.92% |
| Jun 30, 2025 | -20.68% |
| Mar 31, 2025 | -28.84% |
| Dec 31, 2024 | -4.60% |
| Sep 30, 2024 | -24.55% |
| Jun 30, 2024 | -20.36% |
| Mar 31, 2024 | -25.99% |
| Dec 31, 2023 | -23.50% |
| Sep 30, 2023 | -21.23% |
| Jun 30, 2023 | 12.70% |
| Mar 31, 2023 | -1.62% |
| Dec 31, 2022 | -15.38% |
| Sep 30, 2022 | -33.12% |
| Jun 30, 2022 | 5.66% |
| Mar 31, 2022 | -13.46% |
| Dec 31, 2021 | -10.89% |
Opko Health EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OPK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();